Literature DB >> 22707117

Analysis of the role of hepatic PPARγ expression during mouse liver regeneration.

Vered Gazit1, Jiansheng Huang, Alexander Weymann, David A Rudnick.   

Abstract

UNLABELLED: Mice subjected to partial hepatectomy (PH) develop hypoglycemia, followed by increased systemic lipolysis and hepatic fat accumulation, prior to onset of hepatocellular proliferation. Strategies that disrupt these metabolic events inhibit regeneration. These observations suggest that alterations in metabolism in response to hepatic insufficiency promote liver regeneration. Hepatic expression of the peroxisome proliferator-activated receptor gamma (PPARγ) influences fat accumulation in the liver. Therefore, the studies reported here were undertaken to assess the effects of disruption of hepatic PPARγ expression on hepatic fat accumulation and hepatocellular proliferation during liver regeneration. The results showed that liver regeneration was not suppressed, but rather modestly augmented in liver-specific PPARγ null mice maintained on a normal diet. These animals also exhibited accelerated hepatic cyclin D1 expression. Because hepatic PPARγ expression is increased in experimental models of fatty liver disease in which liver regeneration is impaired, regeneration in liver-specific PPARγ null mice with chronic hepatic steatosis was also examined. In contrast to the results described above, disruption of hepatic PPARγ expression in mice with diet-induced hepatic steatosis resulted in significant suppression of hepatic regeneration.
CONCLUSION: The metabolic and hepatocellular proliferative responses to PH are modestly augmented in liver-specific PPARγ null mice, thus providing additional support for a metabolic model of liver regeneration. Furthermore, regeneration is significantly impaired in liver-specific PPARγ null mice in the setting of diet-induced chronic steatosis, suggesting that pharmacological strategies to augment hepatic PPARγ activity might improve regeneration of the fatty liver.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707117      PMCID: PMC3465497          DOI: 10.1002/hep.25880

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Caveolin-1 is essential for liver regeneration.

Authors:  Manuel A Fernández; Cecilia Albor; Mercedes Ingelmo-Torres; Susan J Nixon; Charles Ferguson; Teymuras Kurzchalia; Francesc Tebar; Carlos Enrich; Robert G Parton; Albert Pol
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

2.  The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration.

Authors:  Xinhe Wang; Hiroaki Kiyokawa; Margaret B Dennewitz; Robert H Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

3.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

Authors:  Songtao Yu; Kimihiko Matsusue; Papreddy Kashireddy; Wen-Qing Cao; Vaishalee Yeldandi; Anjana V Yeldandi; M Sambasiva Rao; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

4.  Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.

Authors:  Kaname Yoshizawa; Daniel P Cioca; Shigeyuki Kawa; Eiji Tanaka; Kendo Kiyosawa
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

5.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

6.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Rosiglitazone inhibits mouse liver regeneration.

Authors:  Yumirle P Turmelle; Olga Shikapwashya; Shu Tu; Paul W Hruz; Qingyun Yan; David A Rudnick
Journal:  FASEB J       Date:  2006-10-31       Impact factor: 5.191

8.  Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury.

Authors:  Isabelle A Leclercq; Jacqueline Field; Geoffrey C Farrell
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis.

Authors:  Jens Walldorf; Christoph Hillebrand; Hendryk Aurich; Peggy Stock; Madlen Hempel; Sabine Ebensing; Wolfgang E Fleig; Thomas Seufferlein; Matthias M Dollinger; Bruno Christ
Journal:  Scand J Gastroenterol       Date:  2010-04       Impact factor: 2.423

10.  PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.

Authors:  Erin E Kershaw; Michael Schupp; Hong-Ping Guan; Noah P Gardner; Mitchell A Lazar; Jeffrey S Flier
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-11       Impact factor: 4.310

View more
  22 in total

Review 1.  Elucidating the metabolic regulation of liver regeneration.

Authors:  Jiansheng Huang; David A Rudnick
Journal:  Am J Pathol       Date:  2013-10-17       Impact factor: 4.307

2.  Pre-stimulated Mice with Carbon Tetrachloride Accelerate Early Liver Regeneration After Partial Hepatectomy.

Authors:  Yuko Arioka; Hiroyasu Ito; Tatsuya Ando; Hideyuki Ogiso; Akihiro Hirata; Akira Hara; Mitsuru Seishima
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

3.  Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.

Authors:  Jiansheng Huang; Andrew E Schriefer; Wei Yang; Paul F Cliften; David A Rudnick
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

Review 4.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

5.  Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration.

Authors:  Jiansheng Huang; Emily Barr; David A Rudnick
Journal:  Hepatology       Date:  2013-05       Impact factor: 17.425

Review 6.  Implications of microbiota and bile acid in liver injury and regeneration.

Authors:  Hui-Xin Liu; Ryan Keane; Lili Sheng; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2015-08-07       Impact factor: 25.083

7.  Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.

Authors:  Guomin Xie; Shi Yin; Zhenzhen Zhang; Dan Qi; Xia Wang; Donghwan Kim; Tomoki Yagai; Chad N Brocker; Yan Wang; Frank J Gonzalez; Hua Wang; Aijuan Qu
Journal:  Am J Pathol       Date:  2018-11-16       Impact factor: 4.307

8.  Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration.

Authors:  Jiansheng Huang; Andrew E Schriefer; Paul F Cliften; Dennis Dietzen; Sakil Kulkarni; Sucha Sing; Satdarshan P S Monga; David A Rudnick
Journal:  Am J Pathol       Date:  2016-01-06       Impact factor: 4.307

9.  PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling.

Authors:  Hui-Xin Liu; Yaping Fang; Ying Hu; Frank J Gonzalez; Jianwen Fang; Yu-Jui Yvonne Wan
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors.

Authors:  Stéphane Mandard; David Patsouris
Journal:  PPAR Res       Date:  2013-03-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.